Scilex Holding (SCLX) Short term Debt (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Short term Debt of $80.8 million for Q1 2026, up 104.81% year-over-year from $39.4 million in Q1 2025, and down 2.98% on a QoQ basis from $83.3 million in Q4 2025.
Scilex Holding (SCLX) Short term Debt (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Short term Debt for 5 consecutive years, with $80.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Short term Debt rose 104.81% year-over-year to $80.8 million; the TTM figure through Mar 2026 stood at $80.8 million (up 104.81% YoY), while the FY2025 annual figure was $83.3 million, up 138.74% from the prior year.
- Short term Debt came in at $80.8 million for Q1 2026 at Scilex Holding, down from $83.3 million in the prior quarter.
- The five-year high for Short term Debt was $115.2 million in Q3 2023, with the low at $15.9 million in Q2 2023.
- Average Short term Debt over 4 years is $68.0 million, with a median of $78.1 million recorded in 2024.
- The largest YoY upside for Short term Debt was 373.55% in 2024 against a maximum downside of 67.84% in 2024.
- Year by year, Short term Debt stood at $108.4 million in 2023, then plunged by 67.84% to $34.9 million in 2024, then jumped by 138.74% to $83.3 million in 2025, then dropped by 2.98% to $80.8 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $80.8 million, $83.3 million, and $45.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.78 Mn |
| Dec 31, 2025 | 83.26 Mn |
| Sep 30, 2025 | 45.67 Mn |
| Jun 30, 2025 | 39.87 Mn |
| Mar 31, 2025 | 39.44 Mn |
| Dec 31, 2024 | 34.88 Mn |
| Sep 30, 2024 | 84.64 Mn |
| Jun 30, 2024 | 75.37 Mn |
| Mar 31, 2024 | 92.92 Mn |
| Dec 31, 2023 | 108.43 Mn |
| Sep 30, 2023 | 115.22 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Dec 31, 2021 | 37.95 Mn |